Insider Shareholders with Direct Ownership of Alpine Immune Sciences, Inc. (ALPN)
This section provides a comprehensive overview of the insiders with direct ownership of Alpine Immune Sciences, Inc. (ALPN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ALPINE IMMUNE SCIENCES, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Decheng Capital China Life Sciences Usd Fund Iii, L.P.
> 10% Shareholder |
3,416,645 | 0 | 6,582,380 $0 | 3 |
Jan 18, 2024
Added 15.79%
|
|
Alpine Immuno Sciences, L.P.
> 10% Shareholder |
0 | 1,393,801 | 2,600,980 $0 | 2 |
Sep 17, 2021
Reduced 13.33%
|
|
Decheng Capital Global Healthcare Fund (Master), Lp
> 10% Shareholder |
375,000 | 0 | 1,735,544 $0 | 1 |
Nov 09, 2023
Added 17.77%
|
|
Frazier Life Sciences Viii, L.P.
> 10% Shareholder |
112,665 | 1,200,000 | 1,484,115 $0 | 2 |
Feb 11, 2022
Added 7.06%
|
|
Jay Venkatesan
Director |
216,387 | 0 | 238,126 $0 | 4 |
Jul 15, 2022
Added 7.77%
|
|
Mitchell Gold
Executive Chairman and CEO |
473,688 | 534,322 | 0 $0 | 34 |
May 20, 2024
Reduced 100.0%
|
|
Stanford L Peng
Officer |
319,792 | 348,086 | 0 $0 | 4 |
May 20, 2024
Reduced 100.0%
|
|
James Paul Rickey
Officer |
332,461 | 358,746 | 0 $0 | 27 |
May 20, 2024
Reduced 100.0%
|
|
Remy Durand
Chief Business Officer |
126,488 | 133,392 | 0 $0 | 3 |
May 20, 2024
Reduced 100.0%
|
|
Ulrich Martin Fuhs
Chief Accounting Officer |
22,820 | 30,120 | 0 $0 | 2 |
May 20, 2024
Reduced 100.0%
|